Myhre syndrome in adulthood: clinical variability and emerging genotype-phenotype correlations
Eva Vanbelleghem,Tim Van Damme,Aude Beyens,Sofie Symoens,Kathleen Claes,Julie De Backer,Ilse Meerschaut,Floris Vanommeslaeghe,Sigurd E. Delanghe,Jenneke van den Ende,Tessi Beyltjens,Eleanor R. Scimone,Mark E. Lindsay,Lisa A. Schimmenti,Alicia M. Hinze,Emily Dunn,Natalia Gomez-Ospina,Isabelle Vandernoot,Thomas Delguste,Sandra Coppens,Valérie Cormier-Daire,Marco Tartaglia,Livia Garavelli,Joseph Shieh,Şenol Demir,Esra Arslan Ateş,Martin Zenker,Mersedeh Rohanizadegan,Greysha Rivera-Cruz,Sofia Douzgou,Justin Smith,Jessica Simkins,Don Clark,Stephanie Karatsinides,Sandy Taylor,Ines White,Patti Schultz,Kate Wears,Levi Holder,Kathy Young,Angela E. Lin,Bert Callewaert
DOI: https://doi.org/10.1038/s41431-024-01664-1
2024-07-13
European Journal of Human Genetics
Abstract:Myhre syndrome (MS, MIM 139210) is a rare multisystemic disorder caused by recurrent pathogenic missense variants in SMAD4 . The clinical features have been mainly documented in childhood and comprise variable neurocognitive development, recognizable craniofacial features, a short stature with a pseudo-muscular build, hearing loss, thickened skin, joint limitations, diverse cardiovascular and airway manifestations, and increased fibrosis often following trauma or surgery. In contrast, adults with MS are underreported obscuring potential clinical variability. Here, we describe 24 adults with MS, including 17 diagnosed after the age of 18 years old, and we review the literature on adults with MS. Overall, our cohort shows a milder phenotype as well as lower mortality rates compared to what has been published in literature. Individuals with a codon 500 variant in SMAD4 present with a more pronounced neurodevelopmental and systemic phenotype. However, in contrast to the literature, we observe cardiovascular abnormalities in individuals with the p.(Arg496Cys) variant. In addition, we describe scoliosis as a new manifestation and we report fertility in two additional males with the p.(Arg496Cys). In conclusion, our study contributes novel insights into the clinical variability of MS and underscores the importance of variant-specific considerations, and we provide recommendations for the management of MS in adulthood.
biochemistry & molecular biology,genetics & heredity